Herpesvirus-based infectious titering of recombinant adeno-associated viral vectors

作者: Imran Mohiuddin , Scott Loiler , Irina Zolotukhin , Barry J. Byrne , Terence R. Flotte

DOI: 10.1016/J.YMTHE.2004.08.030

关键词:

摘要: Studies in animals and human clinical trials demonstrate the safety persistence of recombinant adeno-associated viral (rAAV) serotype 2 vectors a variety tissues. rAAV other serotypes are also being developed for efficient gene transfer. To date, literature describing these has relied on physical or transducing titers to determine dose, but few, if any, infectious have been presented. This is due large part lack reagents methods that would facilitate titering than 2. Here, we describe AAV2 ITR-containing pseudotyped with AAV capsid their utility by rAAV1 rAAV5 vectors. Cell lines screened optimal transduction using vector particular expresses marker transgene. Once cell line matched, herpes simplex virus expressing rep cap genes provides helper functions amplify genome. The genomes then detected titer calculated. These generate reliable different serotypes, thus enhancing product characterization reducing risk future applications.

参考文章(51)
Candace Summerford, Richard Jude Samulski, Membrane-Associated Heparan Sulfate Proteoglycan Is a Receptor for Adeno-Associated Virus Type 2 Virions Journal of Virology. ,vol. 72, pp. 1438- 1445 ,(1998) , 10.1128/JVI.72.2.1438-1445.1998
K. Reed Clark, Xinglou Liu, John P. Mcgrath, Philip R. Johnson, Highly purified recombinant adeno-associated virus vectors are biologically active and free of detectable helper and wild-type viruses. Human Gene Therapy. ,vol. 10, pp. 1031- 1039 ,(1999) , 10.1089/10430349950018427
J E Conway, CMJ ap Rhys, I Zolotukhin, S Zolotukhin, N Muzyczka, G S Hayward, B J Byrne, High-titer recombinant adeno-associated virus production utilizing a recombinant herpes simplex virus type I vector expressing AAV-2 rep and cap Gene Therapy. ,vol. 6, pp. 986- 993 ,(1999) , 10.1038/SJ.GT.3300937
L Drittanti, C Rivet, P Manceau, O Danos, M Vega, High throughput production, screening and analysis of adeno-associated viral vectors. Gene Therapy. ,vol. 7, pp. 924- 929 ,(2000) , 10.1038/SJ.GT.3301191
Mark Potter, Kye Chesnut, Nicholas Muzyczka, Terry Flotte, Sergei Zolotukhin, [24] Streamlined large-scale production of recombinant adeno-associated virus (rAAV) vectors Methods in Enzymology. ,vol. 346, pp. 413- 430 ,(2002) , 10.1016/S0076-6879(02)46069-7
G R Cutting, T R Flotte, M Egan, W G Kearns, D Erikson, M J Landrum, S B Fulmer, M C Pang, S A Afione, Recombinant adeno-associated virus (AAV-CFTR) vectors do not integrate in a site-specific fashion in an immortalized epithelial cell line. Gene Therapy. ,vol. 3, pp. 748- 755 ,(1996)
Lydia C. Mathews, John T. Gray, Mark R. Gallagher, Richard O. Snyder, Recombinant adeno-associated viral vector production using stable packaging and producer cell lines. Methods in Enzymology. ,vol. 346, pp. 393- 413 ,(2002) , 10.1016/S0076-6879(02)46068-5
Keyun Qing, Cathryn Mah, Jonathan Hansen, Shangzhen Zhou, Varavani Dwarki, Arun Srivastava, Human fibroblast growth factor receptor 1 is a co-receptor for infection by adeno-associated virus 2 Nature Medicine. ,vol. 5, pp. 71- 77 ,(1999) , 10.1038/4758